E1A as a tumor suppressor gene: commentary re S. Madhusudan et al. A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene.
作者信息
Frisch Steven M
机构信息
The Burnham Institute, La Jolla, California 92037, USA.
出版信息
Clin Cancer Res. 2004 May 1;10(9):2905-7. doi: 10.1158/1078-0432.ccr-04-0644.
Abstract
摘要
Zotero 插件